Ranked #1,624 of 8,699 institutional investors
Integral Health Asset Management, LLC
New York, NY
$1.77B
US stock portfolio at live prices · today −$9.7M (−0.54%)
Live prices, last trade 12:30 PM ET
- Value at quarter end (Q3 2026)
- $1.62B
- Change from Q2 2026
- −$813.6M (−33.38%)
- Positions
- 87 · 35 new, 28 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: call options on $12.2M of stock. $88.9M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesINSM 13.2%RVMD 9.12%EWTX 5.45%CYTK 4.66%SRRK 3.58%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| INSM Insmed Incorporated | 1,600,000 | $233M | 13.2% | Unchanged |
| RVMD Revolution Medicines, Inc. | 1,000,000 | $161M | 9.12% | Reduced −33% |
| EWTX Edgewise Therapeutics, Inc. | 2,400,000 | $96.4M | 5.45% | Added +20% |
| CYTK Cytokinetics, Incorporated | 1,600,000 | $82.4M | 4.66% | Unchanged |
| SRRK Scholar Rock Holding Corporation | 1,255,000 | $63.3M | 3.58% | Added +67% |
| MRK Merck & Co., Inc. | 450,000 | $60.6M | 3.43% | Added +29% |
| CNC Centene Corporation | 750,000 | $48.7M | 2.75% | Added +150% |
| CVS CVS Health Corporation | 500,000 | $41.0M | 2.31% | Reduced −55% |
| VERA Vera Therapeutics, Inc. | 1,500,000 | $38.3M | 2.17% | Reduced −14% |
| REGN Regeneron Pharmaceuticals, Inc. | 40,000 | $37.2M | 2.10% | Unchanged |
| LFST LifeStance Health Group, Inc. | 2,600,000 | $35.5M | 2.01% | Reduced −13% |
| AMGN Amgen Inc. | 75,000 | $32.9M | 1.86% | New |
| AXSM Axsome Therapeutics, Inc. | 250,000 | $32.7M | 1.85% | Reduced −17% |
| RYTM Rhythm Pharmaceuticals, Inc. | 250,000 | $28.2M | 1.59% | Reduced −55% |
| CAH Cardinal Health, Inc. | 100,000 | $27.6M | 1.56% | Reduced −67% |
| BIIB Biogen Inc. | 100,000 | $24.9M | 1.41% | Unchanged |
| THC Tenet Healthcare Corporation | 90,000 | $23.7M | 1.34% | Reduced −45% |
| BBIO BridgeBio Pharma, Inc. | 300,000 | $23.1M | 1.31% | Added +9% |
| NBIX Neurocrine Biosciences, Inc. | 150,000 | $23.0M | 1.30% | Unchanged |
| TNGX Tango Therapeutics, Inc. | 1,000,000 | $22.0M | 1.25% | Unchanged |
| BDX Becton, Dickinson and Company | 100,000 | $21.5M | 1.21% | New |
| GKOS Glaukos Corporation | 90,000 | $21.2M | 1.20% | Reduced −40% |
| VRTX Vertex Pharmaceuticals Incorporated | 40,000 | $21.0M | 1.18% | Unchanged |
| EW Edwards Lifesciences Corporation | 200,000 | $20.7M | 1.17% | Reduced −68% |
| BTSG BrightSpring Health Services, Inc. | 325,000 | $20.6M | 1.16% | Reduced −41% |
| ONC BeOne Medicines AG | 50,000 | $19.8M | 1.12% | New |
| INCY Incyte Corporation | 160,000 | $18.5M | 1.04% | New |
| LBRX LB Pharmaceuticals Inc | 470,000 | $18.2M | 1.03% | Added +213% |
| BSX Boston Scientific Corporation | 400,000 | $17.1M | 0.97% | Reduced −56% |
| EHC Encompass Health Corporation | 120,000 | $16.1M | 0.91% | New |
| ERAS Erasca, Inc. | 1,130,000 | $15.9M | 0.90% | Added +13% |
| NVS Novartis AG | 100,000 | $15.2M | 0.86% | Reduced −50% |
| DFTX Definium Therapeutics, Inc. | 500,000 | $14.4M | 0.81% | Reduced −9% |
| DGX Quest Diagnostics Incorporated | 55,000 | $14.3M | 0.81% | Reduced −73% |
| ORIC ORIC Pharmaceuticals, Inc. | 1,700,000 | $12.7M | 0.72% | Reduced −11% |
| ANRO Alto Neuroscience Inc | 500,000 | $12.5M | 0.71% | Unchanged |
| PRAX Praxis Precision Medicines, Inc. | 40,000 | $12.2M | 0.69% | Unchanged |
| BMY Bristol-Myers Squibb Company | 200,000 | $11.9M | 0.67% | New |
| WAT Waters Corporation | 25,000 | $11.1M | 0.63% | Reduced −38% |
| ABSI Absci Corporation | 1,300,000 | $9.8M | 0.55% | Added +63% |
| MDGL Madrigal Pharmaceuticals, Inc. | 25,000 | $9.7M | 0.55% | Unchanged |
| TVTX Travere Therapeutics, Inc. | 200,000 | $9.6M | 0.54% | Reduced −47% |
| TMO Thermo Fisher Scientific Inc. | 14,000 | $9.5M | 0.54% | New |
| SYRE Spyre Therapeutics, Inc. | 100,000 | $9.4M | 0.53% | Reduced −69% |
| SRZN Surrozen, Inc. | 325,000 | $9.4M | 0.53% | New |
| TYRA Tyra Biosciences, Inc. | 455,000 | $9.1M | 0.51% | New |
| COO The Cooper Companies, Inc. | 150,000 | $8.9M | 0.50% | New |
| RGNX REGENXBIO Inc. | 1,200,000 | $8.4M | 0.48% | Added +50% |
| INSP Inspire Medical Systems, Inc. | 150,000 | $8.4M | 0.47% | Added +50% |
| TGTX TG Therapeutics, Inc. | 125,000 | $8.1M | 0.45% | New |
| OVID Ovid Therapeutics Inc. | 3,500,000 | $7.7M | 0.43% | New |
| VOR Vor Biopharma Inc. | 350,000 | $6.7M | 0.38% | New |
| ATTO Attovia Therapeutics, Inc. | 450,000 | $6.7M | 0.38% | New |
| CLYM Climb Bio Inc | 700,000 | $6.5M | 0.37% | New |
| GH Guardant Health, Inc. | 40,000 | $5.8M | 0.33% | New |
| MLYS Mineralys Therapeutics, Inc. | 400,000 | $5.6M | 0.31% | Reduced −11% |
| COGT Cogent Biosciences, Inc. | 200,000 | $5.4M | 0.30% | Unchanged |
| ELVN Enliven Therapeutics, Inc. | 100,000 | $4.6M | 0.26% | Reduced −33% |
| NGNE Neurogene Inc. | 200,000 | $4.5M | 0.25% | New |
| ALNY Alnylam Pharmaceuticals, Inc. | 30,000 | $4.5M | 0.25% | New |
| IVA Inventiva S.A. | 1,300,000 | $4.2M | 0.24% | Reduced −14% |
| BEAM Beam Therapeutics Inc. | 200,000 | $4.2M | 0.24% | Reduced −33% |
| IONS Ionis Pharmaceuticals, Inc. | 150,000 | $4.1M | 0.23% | New |
| CMPS COMPASS Pathways plc | 460,000 | $3.7M | 0.21% | New |
| ABVX ABIVAX Société Anonyme | 50,000 | $3.7M | 0.21% | New |
| TXG 10x Genomics, Inc. | 70,000 | $3.7M | 0.21% | New |
| APMD Apnimed, Inc. | 225,000 | $3.6M | 0.21% | New |
| SANA Sana Biotechnology, Inc. | 2,000,000 | $3.3M | 0.19% | Unchanged |
| MAZE Maze Therapeutics, Inc. | 100,000 | $3.2M | 0.18% | New |
| CTNM Contineum Therapeutics, Inc. | 345,000 | $3.0M | 0.17% | New |
| ALMS Alumis Inc. | 700,000 | $2.8M | 0.16% | Unchanged |
| TARA Protara Therapeutics, Inc. | 1,250,000 | $2.8M | 0.16% | Reduced −17% |
| KARD Kardigan, Inc. | 225,000 | $2.7M | 0.15% | Added +13% |
| TRVI Trevi Therapeutics, Inc. | 200,000 | $2.7M | 0.15% | Unchanged |
| GLUE Monte Rosa Therapeutics, Inc. | 300,000 | $2.6M | 0.15% | New |
| IDYA IDEAYA Biosciences, Inc. | 100,000 | $2.6M | 0.15% | Unchanged |
| SVRA Savara Inc. | 600,000 | $2.6M | 0.15% | Unchanged |
| NRIX Nurix Therapeutics, Inc. | 160,000 | $2.1M | 0.12% | New |
| FTH Faeth Therapeutics, Inc. | 240,000 | $2.0M | 0.12% | New |
| BRVE Braveheart Bio, Inc. | 100,000 | $2.0M | 0.11% | New |
| CAMP Camp4 Therapeutics Corp | 495,000 | $1.9M | 0.11% | New |
| CAI Caris Life Sciences, Inc. | 100,000 | $1.8M | <0.1% | New |
| IKT Inhibikase Therapeutics, Inc. | 1,350,000 | $1.8M | <0.1% | Unchanged |
| ETRA Electra Therapeutics, Inc. | 200,000 | $1.7M | <0.1% | New |
| AGMB AgomAb Therapeutics NV | 235,000 | $1.3M | <0.1% | New |
| XFOR X4 Pharmaceuticals, Inc. | 250,000 | $755K | <0.1% | New |
| ACRS Aclaris Therapeutics, Inc. | 200,000 | $692K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ABT Abbott Laboratories | 400,000 | $41.6M |
| UNH UnitedHealth Group Incorporated | 85,000 | $29.3M |
| NVO Novo Nordisk A/S | 600,000 | $23.0M |
| LLY Eli Lilly and Company | 15,000 | $20.3M |
| ELV Elevance Health, Inc. | 50,000 | $20.2M |
| LNTH Lantheus Holdings, Inc. | 190,000 | $19.4M |
| NVST Envista Holdings Corporation | 600,000 | $13.8M |
| ACHC Acadia Healthcare Company, Inc. | 400,000 | $13.6M |
| ALHC Alignment Healthcare, Inc. | 2,000,000 | $13.1M |
| GEHC GE HealthCare Technologies Inc. | 150,000 | $12.2M |
| COR Cencora, Inc. | 30,000 | $10.3M |
| BRKR Bruker Corporation | 150,000 | $8.7M |
| ARWR Arrowhead Pharmaceuticals, Inc. | 200,000 | $8.5M |
| IRTC iRhythm Holdings, Inc. | 90,000 | $8.5M |
| XENE Xenon Pharmaceuticals Inc. | 200,000 | $7.4M |
| IART Integra LifeSciences Holdings Corporation | 550,000 | $7.4M |
| BNTX BioNTech SE | 50,000 | $4.0M |
| MOBI Mobia Medical, Inc. | 250,000 | $3.0M |
| MANE Veradermics Inc | 25,000 | $3.0M |
| CLDX Celldex Therapeutics, Inc. | 100,000 | $2.8M |
| RZLT Rezolute, Inc. | 500,000 | $2.0M |
| DNLI Denali Therapeutics Inc. | 100,000 | $1.9M |
| RLMD Relmada Therapeutics, Inc. | 500,000 | $1.4M |
| BIOA BioAge Labs, Inc. | 300,000 | $1.3M |
| AURA Aura Biosciences, Inc. | 170,000 | $1.2M |
| OLMA Olema Oncology, Inc. | 100,000 | $710K |
| SION Sionna Therapeutics, Inc. | 75,000 | $215K |
| TENX Tenax Therapeutics, Inc. | 167,000 | $213K |